Celanese (CE)
(Real Time Quote from BATS)
$147.00 USD
-1.15 (-0.78%)
Updated Jun 4, 2024 10:44 AM ET
3-Hold of 5 3
B Value D Growth A Momentum C VGM
Brokerage Reports
0 items in cart
Celanese Corporation [CE]
Reports for Purchase
Showing records 61 - 80 ( 470 total )
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
3Q22 Follow-Up - 4Q May Be Trough, but Recovery Could Be Slow
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
3Q22 First Look - Bull Case Gets More Complicated; 4Q Guide and M&M Below Expectations
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Chemicals: 3Q22 Preview - Estimates Could Sink to Trough Levels by Year-End
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
M&M EBITDA Flat Q/Q in 2Q May Not Be as Bad as Feared; Still Light vs. Target
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
2Q22 Follow-Up - Guidance May Be Ambitious, in Our View
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
2Q22 First Look - Strong Results, but We See Risks to 2H Guidance
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department